SELENOP and myalgic encephalomeyelitis/chronic fatigue syndrome: This interpretation is supported by the hypothyroid-like clinical characteristics of CFS, and it is tempting to speculate that SELENOP-aAb lead to an acquired form of resistance to thyroid hormone (A-RTH) with impaired local activation of T4 to T3 [53,54].